Waldenström's macroglobulinemia diagnostic study of choice
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia diagnostic study of choice |
|
FDA on Waldenström's macroglobulinemia diagnostic study of choice |
|
CDC on Waldenström's macroglobulinemia diagnostic study of choice |
|
Waldenström's macroglobulinemia diagnostic study of choice in the news |
|
Blogs on Waldenström's macroglobulinemia diagnostic study of choice |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roukoz A. Karam, M.D.[2]
Overview
The diagnosis of Waldenström macroglobulinemia is based on bone marrow biopsy and serum protein analysis.
Diagnostic study of choice
- There is no single diagnostic study of choice for the diagnosis of Waldenström macroglobulinemia, but WM can be diagnosed based on a bone marrow biopsy and an analysis of serum protein components.[1]26980727[2]
References
- ↑ Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005). "Diagnosis and management of Waldenstrom's macroglobulinemia". J Clin Oncol. 23 (7): 1564–77. doi:10.1200/JCO.2005.03.144. PMID 15735132.
- ↑ Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R; et al. (2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375–90. doi:10.1182/blood-2016-01-643569. PMC 4874220. PMID 26980727.